Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains delta-9-tetrahydrocannabinol (THC)...
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
An Overview of Psychoactive Drugs01:28

An Overview of Psychoactive Drugs

Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
Altered States of Awareness01:06

Altered States of Awareness

Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain that...
Magical Thinking01:29

Magical Thinking

Magical thinking encompasses the belief in assumptions that defy logical reasoning yet appear intuitively convincing. It is a common psychological phenomenon that persists across various cultural and individual contexts. While these assumptions contradict empirical evidence and scientific laws, they often serve meaningful psychological roles in promoting emotional resilience and a sense of control, especially under stress or uncertainty.Thought-Action Fusion and the Law of SimilarityA key...
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International cannabis policies and their association with cannabis use, cannabis use disorder, and other psychiatric disorders.

The lancet. Psychiatry·2026
Same author

State Tele-Buprenorphine Prescribing Policies by Medical Professional Type.

JAMA health forum·2026
Same author

A Decade After Legalization: Cannabis Risk Factors Associated With Community Retail Cannabis Exposure Among Adolescents in the Pacific Northwest.

American journal of preventive medicine·2026
Same author

Psilocybin microdosing in the United States: Insights from a nationally representative survey.

Addiction (Abingdon, England)·2026
Same author

Longitudinal assessment of anger trajectories following childhood trauma and combat exposure: Associations with PTSD and alcohol use disorder symptoms.

Military psychology : the official journal of the Division of Military Psychology, American Psychological Association·2026
Same author

High potency cannabis flower use is associated with heavier consumption and risk for cannabis use disorder among young adults in California, United States.

Addiction (Abingdon, England)·2025

Related Experiment Video

Updated: Jun 30, 2026

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

U.S. Psychedelic Use and Microdosing in 2025: Insights from a Probability-Based and Nationally Representative Survey.

Michelle Priest, Beau Kilmer, Ben Senator

    Rand Health Quarterly
    |June 29, 2026
    PubMed
    Summary

    Many US states are exploring alternatives to psychedelic prohibition. This study presents survey data on the use of 11 psychedelic substances, including microdosing prevalence for psilocybin, LSD, and MDMA.

    Keywords:
    Controlled Substances and Illegal DrugsDrug Markets and SupplyDrug Policy and TrendsMental Health Treatment

    More Related Videos

    Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
    07:30

    Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

    Published on: August 18, 2020

    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
    10:17

    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

    Published on: April 23, 2019

    Related Experiment Videos

    Last Updated: Jun 30, 2026

    Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
    07:51

    Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

    Published on: August 1, 2025

    Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
    07:30

    Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

    Published on: August 18, 2020

    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
    10:17

    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

    Published on: April 23, 2019

    Area of Science:

    • Psycho-pharmacology
    • Public Health Policy

    Background:

    • US states are increasingly considering policy changes regarding psychedelic substance prohibition for nonclinical use.
    • This shift necessitates data to inform public health and policy discussions.

    Purpose of the Study:

    • To present new survey data on the usage patterns of 11 psychedelic substances.
    • To analyze the prevalence of microdosing for specific substances like psilocybin, LSD, and MDMA.

    Main Methods:

    • National survey data collection on psychedelic substance use.
    • Analysis of self-reported usage, including frequency and dosage.
    • Specific focus on microdosing patterns for psilocybin, LSD, and MDMA.

    Main Results:

    • Data on the prevalence of use for 11 different psychedelic substances.
    • Detailed findings on the practice of microdosing, including its application to psilocybin, LSD, and MDMA.
    • Insights into current nonclinical psychedelic use trends.

    Conclusions:

    • The findings provide empirical data to inform ongoing policy debates surrounding psychedelic substances.
    • Understanding microdosing prevalence is crucial for future research and regulatory considerations.
    • This study contributes to the evidence base for nonclinical psychedelic use in the US.